Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights.

IF 4.1 2区医学 Q1 SUBSTANCE ABUSE Current Addiction Reports Pub Date : 2022-09-01 DOI:10.1007/s40429-022-00414-x

Michele Bedard-Gilligan, Elizabeth Lehinger, Sarah Cornell-Maier, Ash Holloway, Lori Zoellner

{"title":"Effects of Cannabis on PTSD Recovery: Review of the Literature and Clinical Insights.","authors":"Michele Bedard-Gilligan, Elizabeth Lehinger, Sarah Cornell-Maier, Ash Holloway, Lori Zoellner","doi":"10.1007/s40429-022-00414-x","DOIUrl":null,"url":null,"abstract":"Purpose of review: Individuals with posttraumatic stress disorder (PTSD) may use cannabis to reduce symptoms yet are also at risk for developing problematic use. This review outlines theories, summarizes recent empirical studies, and discusses clinical implications of cannabis use and PTSD recovery.Recent findings: Although naturalistic studies and open trials find a relationship between cannabinoids and PTSD symptom reduction, methodological limitations preclude definitive conclusions. The only randomized controlled trial to date found cannabis had no greater effect on PTSD symptoms than placebo.Summary: Rigorous studies of the long-term impact of cannabis use on PTSD recovery are needed. Clinicians and researchers must weigh the potential therapeutic effect against the costs and risks associated with long-term cannabis use. Clinicians should consider all available PTSD treatment options, along with client level factors such as the function of cannabis use, motivation to change use, and the potential impact of cannabis on treatment engagement when making clinical recommendations.","PeriodicalId":52300,"journal":{"name":"Current Addiction Reports","volume":"9 3","pages":"203-216"},"PeriodicalIF":4.1000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648847/pdf/nihms-1821926.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Addiction Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s40429-022-00414-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}

引用次数: 4

Abstract

Purpose of review: Individuals with posttraumatic stress disorder (PTSD) may use cannabis to reduce symptoms yet are also at risk for developing problematic use. This review outlines theories, summarizes recent empirical studies, and discusses clinical implications of cannabis use and PTSD recovery.

Recent findings: Although naturalistic studies and open trials find a relationship between cannabinoids and PTSD symptom reduction, methodological limitations preclude definitive conclusions. The only randomized controlled trial to date found cannabis had no greater effect on PTSD symptoms than placebo.

Summary: Rigorous studies of the long-term impact of cannabis use on PTSD recovery are needed. Clinicians and researchers must weigh the potential therapeutic effect against the costs and risks associated with long-term cannabis use. Clinicians should consider all available PTSD treatment options, along with client level factors such as the function of cannabis use, motivation to change use, and the potential impact of cannabis on treatment engagement when making clinical recommendations.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

大麻对创伤后应激障碍康复的影响:文献综述和临床见解。

审查目的:患有创伤后应激障碍(PTSD)的个体可能使用大麻来减轻症状，但也有出现问题使用的风险。这篇综述概述了理论，总结了最近的实证研究，并讨论了大麻使用和创伤后应激障碍康复的临床意义。最近的发现:虽然自然主义研究和公开试验发现大麻素和PTSD症状减轻之间的关系，但方法上的局限性排除了明确的结论。迄今为止唯一的随机对照试验发现，大麻对创伤后应激障碍症状的影响并不比安慰剂大。总结:需要对大麻使用对创伤后应激障碍恢复的长期影响进行严格的研究。临床医生和研究人员必须权衡潜在的治疗效果与长期使用大麻的成本和风险。临床医生在提出临床建议时，应考虑所有可用的创伤后应激障碍治疗方案，以及客户层面的因素，如大麻使用的功能、改变使用的动机以及大麻对治疗参与的潜在影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Addiction Reports Psychology-Clinical Psychology

CiteScore

6.60

自引率

4.70%

发文量

期刊介绍： This journal focuses on the prevention, assessment and diagnosis, and treatment of addiction. Designed for physicians and other mental health professionals who need to keep up-to-date with the latest research, Current Addiction Reports offers expert reviews on the most recent and important research in addiction. We accomplish this by appointing leaders in the field to serve as Section Editors in key subject areas and disciplines, such asAlcoholTobaccoStimulants, cannabis, and club drugsBehavioral addictionsGender disparities in addictionComorbid psychiatric disorders and addictionSubstance abuse disorders and HIVSection Editors, in turn, select the most pressing topics as well as experts to evaluate the latest research, report on any controversial discoveries or hypotheses of interest, and ultimately bring readers up-to-date on the topic. Articles represent interdisciplinary endeavors with research from fields such as psychiatry, psychology, pharmacology, epidemiology, and neuroscience.Additionally, an international Editorial Board—representing a range of disciplines within addiction medicine—ensures that the journal content includes current, emerging research and suggests articles of special interest to their country or region.